Financials
| Interim Results | Sep. 26, 2024 |
| 2023 Full Year Results | Jun. 27, 2024 |
| 2022 Full Year Results | Apr. 27, 2023 |
| Interim Results | Sep. 29, 2022 |
| Full Year Results | May. 25, 2022 |
| Interim results | Sep. 30, 2021 |
| Full Year Results | May. 12, 2021 |
Proxies
| Results of AGM and Appointment of New Chairman | Oct. 10, 2024 |
| Appointment of New Chairman and Notice of AGM | Sep. 18, 2024 |
| Result of AGM | Jun. 29, 2023 |
| Annual General Meeting Presentation | Jun. 29, 2023 |
| Result of AGM | Jun. 30, 2022 |
| Posting of Annual Report & Notice of AGM | Jun. 06, 2022 |
| Result of AGM | Jun. 18, 2021 |
Ownership Update
| Holding(s) in Company | Jan. 17, 2025 |
| Grant of Options | Nov. 15, 2023 |
| Holding(s) in Company | Oct. 06, 2022 |
| Grant of Options | Jul. 06, 2022 |
| Holding(s) in Company | Jun. 15, 2022 |
| Holding(s) in Company | Apr. 06, 2022 |
| Holding(s) in Company | Mar. 08, 2022 |
Announcements
| Proposed cancellation of trading on AIM | Mar. 11, 2025 |
| Martin Murphy appointed as Non-Executive Director | Jan. 16, 2025 |
| Result of General Meeting and Total Voting Rights | Jan. 16, 2025 |
| £18m raised to fund Phase 2 INVENT clinical trial | Jan. 15, 2025 |
| Proposed Fundraising | Dec. 20, 2024 |
| Exercise of Share Options and Total Voting Rights | Oct. 30, 2024 |
| Board Change | Sep. 05, 2024 |